 DOLONEUTIN
|
Géminis Farmacéutica
|
| pregabalina |
Antiepiléptico |
| 25 mg cáps.x 30 | $14.035,60 | (17/10/26) |
| PAMI |
|
| AF $6.818,76 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $6.773,52 |
|
|
|
|
| 50 mg cáps.x 30 | $29.900,00 | (17/10/26) |
| PAMI |
|
| AF $13.988,84 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $14.450,76 |
|
|
|
|
| 75 mg cáps.x 15 | $22.091,17 | (17/10/26) |
| PAMI |
|
| AF $9.208,71 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $10.600,45 AF $11.490,72 |
|
|
|
|
| 75 mg cáps.x 30 | $38.400,00 | (17/10/26) |
| PAMI |
|
| AF $18.813,62 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $18.467,53 |
|
|
|
|
| 150 mg cáps.x 30 | $61.491,62 | (17/10/26) |
| PAMI |
|
| AF $29.671,72 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $33.502,10 |
|
|
|
|
| 300 mg cáps.x 30 | $85.900,00 | (17/10/26) |
| PAMI |
|
| AF $33.936,93 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $44.411,79 |
|
|
|
|
| |
